Liu H, Kou F, Hu L, Sun J, et al. Potential candidates for adjuvant olaparib treatment in operable breast cancer patients with germline BRCA1/2 pathogenic variants after neoadjuvant chemotherapy. Breast Cancer Res Treat 2025 Mar 19. doi: 10.1007/s10549-025-07687.
PMID: 40106205